Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Oct-23 8:51 PM View:  | Puissance Capital Managemen... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 13-Oct-23 | Sale | 1,076,840 | $0.10 | $111,776.00 | (100%) 1.08M to 0 | |
| 09-Jun-23 4:12 PM View: | Amin Naseem Director | Bellerophon Therapeutics, I... (BLPH) | 07-Jun-23 | Grant | 47,578 | -- | -- | 19% 244.29K to 291.87K | |
| 07-Jun-23 9:21 PM View: | Puissance Life Science Oppo... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 07-Jun-23 | Sale | 134,421 | $0.83 | $111,569.00 | (11%) 1.21M to 1.08M | |
| 19-May-23 8:55 PM View: | Puissance Life Science Oppo... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 18-May-23 | Private Sale | 560,000 | $9.46 | $5,297,600.00 | (32%) 1.77M to 1.21M | |
| 22-May-23 6:51 PM View: | Kim Bobae VP Reg. Affairs & Quality | Bellerophon Therapeutics, I... (BLPH) | 18-May-23 | Option Exercise | 1,288 | $7.47 | $9,620.10 | 13% 9.89K to 11.18K | |
| 22-May-23 6:51 PM View: | Kim Bobae VP Reg. Affairs & Quality | Bellerophon Therapeutics, I... (BLPH) | 18-May-23 | Option Sale | 1,288 | $10.00 | $12,880.00 | (12%) 11.18K to 9.89K | |
| 22-May-23 6:51 PM View: | Kim Bobae VP Reg. Affairs & Quality | Bellerophon Therapeutics, I... (BLPH) | 18-May-23 | Sale | 8,167 | $10.00 | $81,670.00 | (83%) 9.89K to 1.72K | |
| 14-Feb-23 7:32 PM View: | Amin Naseem Director | Bellerophon Therapeutics, I... (BLPH) | 10-Feb-23 | Grant | 84,000 | -- | -- | 52% 160.29K to 244.29K | |
| 13-Dec-22 5:25 PM View: | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Payment of Exercise | 5,530 | $0.93 | $5,143.45 | (31%) 18.0K to 12.47K | |
| 13-Dec-22 5:26 PM View: | Dekker Martin VP OF ENGINEERING & MANUFACTUR | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Option Exercise | 25,500 | -- | -- | 100% 0 to 25.5K | |
| 13-Dec-22 5:25 PM View: | Shah Parag Suresh VP of Business Operations | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Payment of Exercise | 7,834 | $0.93 | $7,286.40 | (31%) 25.5K to 17.67K | |
| 13-Dec-22 5:25 PM View: | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Option Exercise | 18,000 | -- | -- | 100% 0 to 18.0K | |
| 13-Dec-22 5:25 PM View: | Fernandes Peter PRINCIPAL EXECUTIVE OFFICER | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Payment of Exercise | 9,985 | $0.93 | $9,287.05 | (31%) 32.5K to 22.52K | |
| 13-Dec-22 5:25 PM View: | Shah Parag Suresh VP of Business Operations | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Option Exercise | 25,500 | -- | -- | 100% 0 to 25.5K | |
| 13-Dec-22 5:26 PM View: | Dekker Martin VP OF ENGINEERING & MANUFACTUR | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Payment of Exercise | 7,834 | $0.93 | $7,286.40 | (31%) 25.5K to 17.67K | |
| 13-Dec-22 5:25 PM View: | Fernandes Peter PRINCIPAL EXECUTIVE OFFICER | Bellerophon Therapeutics, I... (BLPH) | 09-Dec-22 | Option Exercise | 32,500 | -- | -- | 100% 0 to 32.5K | |
| 04-Jan-22 4:10 PM View: | Amin Naseem Director | Bellerophon Therapeutics, I... (BLPH) | 31-Dec-21 | Grant | 39,032 | -- | -- | 32% 121.25K to 160.29K | |
| 08-Jun-21 12:37 PM View: | Puissance Life Science Oppo... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 07-Jun-21 | Grant | 8,189 | $4.00 | $32,756.00 | < 1% 1.76M to 1.77M | |
| 26-Apr-21 12:39 PM View: | Puissance Life Science Oppo... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 26-Apr-21 | Grant | 609,231 | $4.00 | $2,436,920.00 | 53% 1.15M to 1.76M | |
| 02-Apr-21 4:10 PM View: | Peacock Jonathan M Director | Bellerophon Therapeutics, I... (BLPH) | 31-Mar-21 | Grant | 15,308 | -- | -- | 11% 141.72K to 157.03K | |
| 22-Mar-21 9:36 PM View: | New Mountain Investments Ii... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 18-Mar-21 | Sale | 400,000 | $5.48 | $2,192,000.00 | (40%) 1.01M to 609.23K | |
| 14-Sep-20 8:31 AM View: | Fares Wassim Chief Medical Officer | Bellerophon Therapeutics, I... (BLPH) | 10-Sep-20 | Market Purchase | 4,000 | $10.18 | $40,708.00 | 100% 0 to 4.0K | (23%) |
| 09-Jun-20 4:01 PM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 08-Jun-20 | Market Purchase | 2,600 | $12.87 | $33,454.20 | 4% 58.31K to 60.91K | (39%) |
| 09-Jun-20 4:01 PM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 05-Jun-20 | Market Purchase | 4,986 | $12.72 | $63,441.90 | 9% 53.33K to 58.31K | (38%) |
| 22-May-20 7:25 AM View: | Puissance Life Science Oppo... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 21-May-20 | Grant | 1,153,850 | $13.00 | $15,000,000.00 | 100% 0 to 1.15M | (40%) |
| 20-Apr-20 10:47 AM View: | Puissance Cross-Border Oppo... 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 17-Apr-20 | Disposition (other) | 553,250 | -- | -- | (100%) 553.25K to 0 | |
| 27-Jan-20 4:51 PM View: | Peacock Jonathan M Director | Bellerophon Therapeutics, I... (BLPH) | 23-Jan-20 | Grant | 350,000 | -- | -- | 19% 1.88M to 2.23M | |
| 25-Nov-19 4:52 PM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 25-Nov-19 | Market Purchase | 7,193 | $0.39 | $2,773.62 | 1% 585.73K to 592.92K | 36% |
| 25-Nov-19 4:52 PM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 22-Nov-19 | Market Purchase | 1,050 | $0.37 | $393.54 | < 1% 584.68K to 585.73K | 41% |
| 25-Nov-19 4:52 PM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 21-Nov-19 | Market Purchase | 200 | $0.37 | $74.00 | < 1% 584.48K to 584.68K | 40% |
| 19-Nov-19 4:36 PM View: | Shah Parag Suresh VP of Business Operations | Bellerophon Therapeutics, I... (BLPH) | 15-Nov-19 | Payment of Exercise | 25,993 | $0.34 | $8,837.62 | (20%) 131.6K to 105.61K | (55%) |
| 19-Nov-19 4:35 PM View: | Korner Assaf CFO | Bellerophon Therapeutics, I... (BLPH) | 15-Nov-19 | Payment of Exercise | 32,987 | $0.34 | $11,215.60 | (33%) 99.06K to 66.08K | (55%) |
| 19-Nov-19 4:36 PM View: | Tenenbaum Fabian Chief Executive Officer Director | Bellerophon Therapeutics, I... (BLPH) | 15-Nov-19 | Payment of Exercise | 76,823 | $0.34 | $26,119.80 | (16%) 484.28K to 407.46K | (55%) |
| 19-Nov-19 4:35 PM View: | Dekker Martin VP of Engineering & Manuf | Bellerophon Therapeutics, I... (BLPH) | 15-Nov-19 | Payment of Exercise | 27,134 | $0.34 | $9,225.56 | (18%) 151.75K to 124.62K | (55%) |
| 19-Nov-19 4:36 PM View: | Fernandes Peter Chief Regulatory & Safety Offr | Bellerophon Therapeutics, I... (BLPH) | 15-Nov-19 | Payment of Exercise | 40,280 | $0.34 | $13,695.20 | (18%) 222.3K to 182.02K | (55%) |
| 28-Oct-19 5:15 PM View: | Venrock Associates Iv L P 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 28-Oct-19 | Market Sale | 333,010 | $0.44 | $146,091.00 | (5%) 6.77M to 6.44M | (26%) |
| 28-Oct-19 5:17 PM View: | Venrock Associates Iv L P 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 28-Oct-19 | Market Sale Duplicate | 333,010 | $0.44 | $146,091.00 | (5%) 6.77M to 6.44M | (26%) |
| 28-Oct-19 5:15 PM View: | Venrock Associates Iv L P 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 25-Oct-19 | Market Sale | 56,242 | $0.45 | $25,511.40 | (< 1%) 6.82M to 6.77M | (22%) |
| 28-Oct-19 5:17 PM View: | Venrock Associates Iv L P 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 25-Oct-19 | Market Sale Duplicate | 56,242 | $0.45 | $25,511.40 | (< 1%) 6.82M to 6.77M | (22%) |
| 28-Oct-19 5:15 PM View: | Venrock Associates Iv L P 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 24-Oct-19 | Market Sale | 704,595 | $0.50 | $353,354.00 | (9%) 7.53M to 6.82M | (9%) |
| 28-Oct-19 5:17 PM View: | Venrock Associates Iv L P 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 24-Oct-19 | Market Sale Duplicate | 704,595 | $0.50 | $353,354.00 | (9%) 7.53M to 6.82M | (9%) |
| 14-Jun-19 11:46 AM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 12-Jun-19 | Market Purchase | 50,000 | $0.64 | $31,905.00 | 9% 534.48K to 584.48K | (13%) |
| 23-May-19 4:46 PM View: | Edmonds Amy VP Clinical Operations & Admin | Bellerophon Therapeutics, I... (BLPH) | 22-May-19 | Payment of Exercise | 35,827 | $0.61 | $21,797.10 | (20%) 176.04K to 140.22K | 8% |
| 24-May-19 9:30 AM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 22-May-19 | Market Purchase | 27,500 | $0.60 | $16,533.00 | 5% 506.98K to 534.48K | (7%) |
| 22-May-19 11:15 AM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 21-May-19 | Market Purchase | 43,280 | $0.61 | $26,370.50 | 9% 463.7K to 506.98K | (8%) |
| 22-May-19 11:14 AM View: | Peacock Jonathan M Director | Bellerophon Therapeutics, I... (BLPH) | 21-May-19 | Market Purchase | 20,000 | $0.61 | $12,198.00 | 1% 1.86M to 1.88M | (8%) |
| 22-May-19 11:14 AM View: | Tenenbaum Fabian Chief Executive Officer Director | Bellerophon Therapeutics, I... (BLPH) | 21-May-19 | Market Purchase | 5,000 | $0.60 | $2,975.00 | 1% 479.28K to 484.28K | (6%) |
| 25-Jan-19 4:12 PM View: | Amin Naseem Director | Bellerophon Therapeutics, I... (BLPH) | 25-Jan-19 | Market Purchase | 571,429 | $0.70 | $400,000.00 | 46% 1.25M to 1.82M | (20%) |
| 25-Jan-19 4:21 PM View: | Peacock Jonathan M Director | Bellerophon Therapeutics, I... (BLPH) | 25-Jan-19 | Market Purchase | 714,286 | $0.70 | $500,000.00 | 63% 1.14M to 1.86M | (20%) |
| 25-Jan-19 4:22 PM View: | Wang Theodore T Director 10% Owner | Bellerophon Therapeutics, I... (BLPH) | 25-Jan-19 | Market Purchase | 450,000 | $0.70 | $315,000.00 | 3285% 13.7K to 463.7K | (20%) |
